Stock Highlights: Acceleron Pharma, Inc. (NASDAQ:XLRN), Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), Micron Technology, Inc. (NASDAQ:MU), KeyCorp. (NYSE:KEY),

Acceleron Pharma, Inc. (NASDAQ:XLRN) said that, it will present Cowen and Company 36th Annual Health Care Conference on 9 March.

Acceleron Pharma, Inc. (NASDAQ:XLRN) belongs to Healthcare sector. Its weekly performance is 12.44%. On last trading day company shares ended up at $28.47. Acceleron Pharma, Inc. (NASDAQ:XLRN) distance from 50-day simple moving average (SMA50) is 4.37%.

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) announced that the Company will release its fourth quarter and full year 2015 financial results after market close on Thursday, March 10, 2016.

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) shares advanced 7.69% in last trading session and ended the day at $6.02. DRNA return on assets is -56.50%. Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) quarterly performance is -58.45%.

Micron Technology, Inc. (NASDAQ:MU) had its price objective cut by Cowen and Company from $22.00 to $20.00 in a research report published on Tuesday morning, Market Beatreports. They currently have an outperform rating on the semiconductor manufacturer’s stock.

Micron Technology, Inc. (NASDAQ:MU) belongs to Technology sector. Its net profit margin is 14.00% and weekly performance is 11.03%. On last trading day company shares ended up at $11.88. Micron Technology, Inc. (NASDAQ:MU) distance from 50-day simple moving average (SMA50) is 15.85%.

KeyCorp. (NYSE:KEY) announced that Don Kimble, Chief Financial Officer, andChris Gorman, President of Key Corporate Bank, will present at the RBC Capital Markets Financial Institutions Conference in New York City on Tuesday, March 8, 2016, at 8:30 a.m. ET.

KeyCorp. (NYSE:KEY) shares moved up 0.70% in last trading session and ended the day at $11.55. KEY return on assets is 0.90%. KeyCorp. (NYSE:KEY) quarterly performance is -11.41%.

Delta Air Lines, Inc. (NYSE:DAL) signed up as the first title sponsor of this year’s Marianas March against Cancer.

On 04 March, Delta Air Lines, Inc. (NYSE:DAL) shares fell -0.25% and was closed at $48.67. DAL EPS growth in last 5 year was 51.70%. Delta Air Lines, Inc. (NYSE:DAL) year to date (YTD) performance is -3.68%.

Leave a Reply

Your email address will not be published. Required fields are marked *